0IMT Stock Overview
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0IMT from our risk checks.
Photocure ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr53.90 |
| 52 Week High | kr71.90 |
| 52 Week Low | kr40.85 |
| Beta | 0.89 |
| 1 Month Change | -6.27% |
| 3 Month Change | -21.78% |
| 1 Year Change | 0.071% |
| 3 Year Change | -60.49% |
| 5 Year Change | 25.58% |
| Change since IPO | 18.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0IMT | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -1.7% | -1.3% | -0.9% |
| 1Y | 0.07% | -5.5% | -1.8% |
Return vs Industry: 0IMT exceeded the UK Pharmaceuticals industry which returned -5.5% over the past year.
Return vs Market: 0IMT exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
| 0IMT volatility | |
|---|---|
| 0IMT Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 8.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0IMT's share price has been volatile over the past 3 months.
Volatility Over Time: 0IMT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 88 | Dan Schneider | www.photocure.com |
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix.
Photocure ASA Fundamentals Summary
| 0IMT fundamental statistics | |
|---|---|
| Market cap | kr1.46b |
| Earnings (TTM) | kr267.00k |
| Revenue (TTM) | kr500.66m |
5,472x
P/E Ratio2.9x
P/S RatioIs 0IMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0IMT income statement (TTM) | |
|---|---|
| Revenue | kr500.66m |
| Cost of Revenue | kr26.14m |
| Gross Profit | kr474.52m |
| Other Expenses | kr474.25m |
| Earnings | kr267.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 0.0098 |
| Gross Margin | 94.78% |
| Net Profit Margin | 0.053% |
| Debt/Equity Ratio | 0% |
How did 0IMT perform over the long term?
See historical performance and comparison